155 related articles for article (PubMed ID: 25881484)
1. CB1 cannabinoid receptor agonist inhibits matrix metalloproteinase activity in spinal cord injury: A possible mechanism of improved recovery.
Hong J; Nandiwada V; Jones V; Lu M; Warner DS; Mukhopadhyay S; Sheng H
Neurosci Lett; 2015 Jun; 597():19-24. PubMed ID: 25881484
[TBL] [Abstract][Full Text] [Related]
2. Arachidonyl-2'-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model.
Luszczki JJ; Czuczwar P; Cioczek-Czuczwar A; Czuczwar SJ
Eur J Pharmacol; 2006 Oct; 547(1-3):65-74. PubMed ID: 16930590
[TBL] [Abstract][Full Text] [Related]
3. Selective Inhibition of MMP-2 Does Not Alter Neurological Recovery after Spinal Cord Injury.
Gao M; Zhang H; Trivedi A; Mahasenan KV; Schroeder VA; Wolter WR; Suckow MA; Mobashery S; Noble-Haeusslein LJ; Chang M
ACS Chem Neurosci; 2016 Nov; 7(11):1482-1487. PubMed ID: 27551907
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events.
Noble LJ; Donovan F; Igarashi T; Goussev S; Werb Z
J Neurosci; 2002 Sep; 22(17):7526-35. PubMed ID: 12196576
[TBL] [Abstract][Full Text] [Related]
5. Matrix Metalloproteinase-8 Inhibition Prevents Disruption of Blood-Spinal Cord Barrier and Attenuates Inflammation in Rat Model of Spinal Cord Injury.
Kumar H; Jo MJ; Choi H; Muttigi MS; Shon S; Kim BJ; Lee SH; Han IB
Mol Neurobiol; 2018 Mar; 55(3):2577-2590. PubMed ID: 28421532
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury.
Hsu JY; McKeon R; Goussev S; Werb Z; Lee JU; Trivedi A; Noble-Haeusslein LJ
J Neurosci; 2006 Sep; 26(39):9841-50. PubMed ID: 17005848
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptor type 1 agonist ACEA improves motor recovery and protects neurons in ischemic stroke in mice.
Caltana L; Saez TM; Aronne MP; Brusco A
J Neurochem; 2015 Nov; 135(3):616-29. PubMed ID: 26296704
[TBL] [Abstract][Full Text] [Related]
8. Melatonin improves functional outcome via inhibition of matrix metalloproteinases-9 after photothrombotic spinal cord injury in rats.
Piao MS; Lee JK; Jang JW; Hur H; Lee SS; Xiao L; Kim HS
Acta Neurochir (Wien); 2014 Nov; 156(11):2173-82. PubMed ID: 24879621
[TBL] [Abstract][Full Text] [Related]
9. Chronic activation of cannabinoid receptors in vitro does not compromise mouse islet function.
Vilches-Flores A; Hauge-Evans AC; Jones PM; Persaud SJ
Clin Sci (Lond); 2013 Apr; 124(7):467-78. PubMed ID: 23078523
[TBL] [Abstract][Full Text] [Related]
10. Fluoxetine inhibits matrix metalloprotease activation and prevents disruption of blood-spinal cord barrier after spinal cord injury.
Lee JY; Kim HS; Choi HY; Oh TH; Yune TY
Brain; 2012 Aug; 135(Pt 8):2375-89. PubMed ID: 22798270
[TBL] [Abstract][Full Text] [Related]
11. Dl-3-n-butylphthalide Attenuates Spinal Cord Injury via Regulation of MMPs and Junction Proteins in Mice.
Zheng B; Jin Y; Mi S; Xu W; Yang X; Hong Z; Wang Z
Neurochem Res; 2021 Sep; 46(9):2297-2306. PubMed ID: 34086144
[TBL] [Abstract][Full Text] [Related]
12. Sulforaphane attenuates matrix metalloproteinase-9 expression following spinal cord injury in mice.
Mao L; Wang HD; Wang XL; Qiao L; Yin HX
Ann Clin Lab Sci; 2010; 40(4):354-60. PubMed ID: 20947810
[TBL] [Abstract][Full Text] [Related]
13. Valproic acid attenuates blood-spinal cord barrier disruption by inhibiting matrix metalloprotease-9 activity and improves functional recovery after spinal cord injury.
Lee JY; Kim HS; Choi HY; Oh TH; Ju BG; Yune TY
J Neurochem; 2012 Jun; 121(5):818-29. PubMed ID: 22409448
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of selective cannabinoid CB(1) and CB(2) receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis.
Tambaro S; Casu MA; Mastinu A; Lazzari P
Eur J Pharmacol; 2014 Apr; 729():67-74. PubMed ID: 24561047
[TBL] [Abstract][Full Text] [Related]
15. Metalloproteinase increases in the injured rat spinal cord.
de Castro RC; Burns CL; McAdoo DJ; Romanic AM
Neuroreport; 2000 Nov; 11(16):3551-4. PubMed ID: 11095516
[TBL] [Abstract][Full Text] [Related]
16. Ghrelin inhibits BSCB disruption/hemorrhage by attenuating MMP-9 and SUR1/TrpM4 expression and activation after spinal cord injury.
Lee JY; Choi HY; Na WH; Ju BG; Yune TY
Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2403-12. PubMed ID: 25261791
[TBL] [Abstract][Full Text] [Related]
17. Further Evidence for the Neuroplastic Role of Cannabinoids: A Study in Organotypic Hippocampal Slice Cultures.
Caltana LR; Heimrich B; Brusco A
J Mol Neurosci; 2015 Aug; 56(4):773-781. PubMed ID: 25645684
[TBL] [Abstract][Full Text] [Related]
18. An adverse role for matrix metalloproteinase 12 after spinal cord injury in mice.
Wells JE; Rice TK; Nuttall RK; Edwards DR; Zekki H; Rivest S; Yong VW
J Neurosci; 2003 Nov; 23(31):10107-15. PubMed ID: 14602826
[TBL] [Abstract][Full Text] [Related]
19. Post-trauma Lipitor treatment prevents endothelial dysfunction, facilitates neuroprotection, and promotes locomotor recovery following spinal cord injury.
Pannu R; Christie DK; Barbosa E; Singh I; Singh AK
J Neurochem; 2007 Apr; 101(1):182-200. PubMed ID: 17217414
[TBL] [Abstract][Full Text] [Related]
20. The combination of selective inhibition of the cannabinoid CB1 receptor and activation of the cannabinoid CB2 receptor yields improved attenuation of motor and autonomic deficits in a mouse model of spinal cord injury.
Heller JE; Baty DE; Zhang M; Li H; Adler M; Ganea D; Gaughan J; Loftus CM; Jallo JI; Tuma RF
Clin Neurosurg; 2009; 56():84-92. PubMed ID: 20214038
[No Abstract] [Full Text] [Related]
[Next] [New Search]
